
Moa Lundkvist contributed to the Clinical-Genomics/scout repository by developing and enhancing clinical genomics features, including the integration of ClinGen-CGC-VICC and ESCAT classification systems for cancer variant interpretation. She implemented backend and frontend changes using Python, JavaScript, and SQL, focusing on data modeling, configuration management, and UI improvements to support accurate variant classification and reporting. Her work addressed both feature development and critical bug fixes, such as aligning conflict rules with updated clinical guidelines. Moa’s approach emphasized maintainability, clear documentation, and traceable commits, resulting in robust, user-focused solutions that improved data integrity and clinical decision support within Scout.

September 2025: Delivered the ESCAT Classification System for Cancer Variants in Scout. Expanded tiering to include ESCAT tiers alongside AMP tiers, with updates to the database adapters, constants, and user interface to support the new classification. This change enhances variant prioritization, aligns Scout with ESCAT guidelines, and establishes a foundation for future classification expansions.
September 2025: Delivered the ESCAT Classification System for Cancer Variants in Scout. Expanded tiering to include ESCAT tiers alongside AMP tiers, with updates to the database adapters, constants, and user interface to support the new classification. This change enhances variant prioritization, aligns Scout with ESCAT guidelines, and establishes a foundation for future classification expansions.
August 2025: Delivered a critical bug fix in the Scout project to align ClinGen-CGC-VICC variant classification with Horak et al. guidelines, resolving inconsistencies in CCV_POTENTIAL_CONFLICTS. The change enhances accuracy and consistency of variant interpretation across workflows and reinforces governance around conflict rules. All work was performed in the Clinical-Genomics/scout repository with a clearly traceable commit and linked to the related guidance update.
August 2025: Delivered a critical bug fix in the Scout project to align ClinGen-CGC-VICC variant classification with Horak et al. guidelines, resolving inconsistencies in CCV_POTENTIAL_CONFLICTS. The change enhances accuracy and consistency of variant interpretation across workflows and reinforces governance around conflict rules. All work was performed in the Clinical-Genomics/scout repository with a clearly traceable commit and linked to the related guidance update.
March 2025 monthly summary for Clinical-Genomics/scout: Implemented an external resource link to cancerhotspots.org on the variant page for cancer cases, updated the changelog, and ensured gene linking remains correct with the new resource. No major defects fixed this month; all work focused on feature integration and validation. The changes enhance data accessibility, improve decision support, and strengthen traceability through explicit commit documentation.
March 2025 monthly summary for Clinical-Genomics/scout: Implemented an external resource link to cancerhotspots.org on the variant page for cancer cases, updated the changelog, and ensured gene linking remains correct with the new resource. No major defects fixed this month; all work focused on feature integration and validation. The changes enhance data accessibility, improve decision support, and strengthen traceability through explicit commit documentation.
February 2025: Delivered a configurable HRD (Homologous Recombination Deficiency) status feature for cancer cases in the Scout repository, enabling clinicians to toggle HRD checks and view HRD status within diagnostics. This involved configuration changes, data model updates, and UI enhancements to surface actionable diagnostic information. The HRD capability was also added to the demo cancer dataset to illustrate its usage in real scenarios.
February 2025: Delivered a configurable HRD (Homologous Recombination Deficiency) status feature for cancer cases in the Scout repository, enabling clinicians to toggle HRD checks and view HRD status within diagnostics. This involved configuration changes, data model updates, and UI enhancements to surface actionable diagnostic information. The HRD capability was also added to the demo cancer dataset to illustrate its usage in real scenarios.
January 2025 monthly summary for Clinical-Genomics/scout: Implemented and visible CCV score in case reports, enhanced case report presentation, and improved UI readability; documented changes in changelog; all changes are focused on strengthening clinical decision support and reporting accuracy. The work was delivered with clean commits, small scope, and clear traceability, laying groundwork for future CCV analytics and broader adoption.
January 2025 monthly summary for Clinical-Genomics/scout: Implemented and visible CCV score in case reports, enhanced case report presentation, and improved UI readability; documented changes in changelog; all changes are focused on strengthening clinical decision support and reporting accuracy. The work was delivered with clean commits, small scope, and clear traceability, laying groundwork for future CCV analytics and broader adoption.
December 2024 monthly summary for Clinical-Genomics/scout: Focused on improving release notes quality and ensuring changelog accuracy. A changelog fix added an unreleased ClinGen-CGC-VICC oncogenicity classification entry and removed duplicates under 4.92, improving release clarity for stakeholders.
December 2024 monthly summary for Clinical-Genomics/scout: Focused on improving release notes quality and ensuring changelog accuracy. A changelog fix added an unreleased ClinGen-CGC-VICC oncogenicity classification entry and removed duplicates under 4.92, improving release clarity for stakeholders.
November 2024 monthly summary focused on ClinGen-CGC-VICC (CCV) classification enhancements in Scout, with backend, UI, and test coverage improvements. Delivered end-to-end CCV classification support in case reports, plus UI refinements and documentation updates that improve data integrity and user experience.
November 2024 monthly summary focused on ClinGen-CGC-VICC (CCV) classification enhancements in Scout, with backend, UI, and test coverage improvements. Delivered end-to-end CCV classification support in case reports, plus UI refinements and documentation updates that improve data integrity and user experience.
Overview of all repositories you've contributed to across your timeline